Please login to the form below

Not currently logged in

Novasep appoints board chairman

CEO Michel Spagnol takes on dual role

Novasep Michel Spagnol Novasep has named CEO Michel Spagnol as its chairman of the supervisory board.

Spagnol has led the executive team at the French manufacturing firm since June 2013, and will now add supervisory leadership to his role following the departure of former chairman Roger-Marc Nicoud.

During his short time as CEO, Spagnol has already instigated several changes, including the appointments of a new chief financial officer and presidents of both the synthesis business and industrial biotech units.

Prior to joining Novasep, Spagnol was president and chief technology officer at Shasun having previously been with Rhodia.

“Novasep is evolving, with a strong leadership team and a new logo 'Passion and smart processes', representing our refocused strategy,” said Spagnol. “We will continue building on our strong foundations while developing on the excellence of our services and technologies. I wish Roger-Marc continued success in his new endeavours."

5th March 2014

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...